✦ LIBER ✦

Thalidomide use may be linked to second primary malignancies

✍ Scribed by Joanny, J. -F.; Kruse, K.; Prost, J.; Ramaswamy, S.

Book ID: 121635462
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2013
Weight: 111 KB
Volume: 1453
Category: Article
ISSN: 0114-9954
DOI: 10.1007/s40278-013-3236-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Calcium channel blocker use may be linke

Calcium channel blocker use may be linked to breast cancer

✍ Boyers, Dwayne; Jia, Xueli; Jenkinson, David; Mowatt, Graham 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 111 KB

Primary prevention of malignant melanoma

Primary prevention of malignant melanoma: To know may not be enough

✍ Jemec, Gregor B.E 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 465 KB

Second primary malignant melanoma on a s

Second primary malignant melanoma on a skin graft used to cover the defect of the first primary's wide excision

✍ IE Gamatsi; TA McCulloch; L Sully 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 301 KB

Glutathione concentration may be a usefu

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer

✍ Junzo Kigawa; Yukihisa Minagawa; Yasunobu Kanamori; Hiroaki Itamochi; Xiusi Chen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

in tumor samples was determined by immunohistochemical staining and Western blot analysis. GSH concentration was measured by an enzymatic assay. Department of Obstetrics and Gynecology, Tot- ## RESULTS. The response rate was 38.4%. The estimated 3-year survival rate for tori University School of

Incidence of plasma cell dyscrasia as a

Incidence of plasma cell dyscrasia as a second primary malignancy may be low in postmenopausal breast cancer survivors treated with selective estrogen receptor modulator or aromatase inhibitor

✍ Kadri Altundag; Mevlut Kurt; Rabiul Islam; Ozden Altundag; Selahattin Turen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 37 KB

High mutagen sensitivity in head and nec

High mutagen sensitivity in head and neck squamous cell carcinoma (HNSCC) patients may be used for estimation of risk for second primary tumors

✍ J. Cloos; I. Steen; B.J.M. Braakhuis; G.B. Snow 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 173 KB